Track A
Basic and translational science
Viral origins, evolution and diversity (1)
HIV biology (entry, replicative cycle, transcriptional expression and regulation) (11)
Viral fitness, persistence and resistance (3)
Systemic immune activation and inflammation (14)
Correlates of HIV susceptibility, and progression versus control (biomarkers and genetics) (3)
Innate immunity (including NK cells) (8)
Humoral immunity (including broadly neutralizing antibodies), Antibodies and B cells (4)
Cellular immunity; T cell vaccines (7)
Mucosal immunity (5)
Novel vectors, adjuvants and strategies (3)
Immune mechanisms of natural or post-treatment control (4)
Host cellular factors and viral mechanisms of HIV/SIV persistence and latency (12)
Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus (15)
Strategies to reduce/eliminate viral reservoirs (11)
Immunotherapy (including broadly neutralizing antibodies) (7)
ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics (7)
HIV and co-morbidities (8)
HIV and co-infections (TB, viral hepatitis, SARS-CoV2, other) (5)
Neuropathogenesis (2)
SARS-Cov2 Viral origins, evolution and diversity (1)
Immune responses to SARS-Cov2 (8)
SARS-Cov2 vaccines (13)
Strategies to control virologic rebound (1)
Gene therapy (1)
HIV transmission and dissemination (3)
Track B
Clinical science
Impact of co-factors (e.g., viral clade, tropism, genetic factors) on disease progression (2)
Morbidity, mortality and life expectancy in clinical research (5)
Novel assays of immune responses (2)
Novel approaches to assess viral load and ARV resistance/tropism (2)
HIV testing, self-testing and retesting (e.g., point-of-care diagnostics) (2)
Diagnosis of HIV disease in paediatric and adolescent populations (1)
Viral load and CD4 monitoring (11)
Adherence testing (2)
Diagnostics of co-infections and co-morbidities (9)
Biomarkers for the prediction of morbidity and mortality (3)
Tuberculosis: Prevention, diagnosis, treatment (19)
Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections (8)
Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) (9)
STIs (including HPV) (12)
Neurologic disorders (e.g. CNS malignancies) (2)
Mental health (including depression and psychiatric manifestations) and HIV (18)
Malignancies (AIDS and non-AIDS) (8)
Cardiovascular disease (8)
Renal disease (1)
Other non-communicable diseases (9)
Metabolic, lipid and endocrine complications (including lipodystrophy) (3)
Weight gain (14)
Hepatic complications (e.g., NASH) (3)
Other ART complications and adverse reactions (5)
Polypharmacy (1)
Frailty (4)
Drug-drug interaction (DDI) (1)
Other issues related to aging with HIV (11)
ART in acute, first- and second-line therapies (13)
ART in highly treatment-experienced persons (8)
Regimen simplification and switch studies (13)
Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring (9)
Drug interactions (1)
Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) (10)
Adherence (5)
Sex-specific (including cis- and transgender) issues of ART efficacy, adverse reactions and complications (2)
Pregnancy (clinical management issues and pharmacokinetics) and contraception (9)
ARV management strategies in paediatric and adolescent populations (14)
Cure strategies in paediatric and adolescent populations (2)
Adherence in paediatric and adolescent populations (7)
HIV complications and co-morbidities in paediatric and adolescent populations (3)
HIV-associated co-infections and malignancies in paediatric and adolescent populations (2)
Behavioural health outcomes in paediatric and adolescent populations (1)
Mental health and neurocognition in paediatric and adolescent populations (2)
Transition of adolescents into adult care (1)
Clinical issues in sex workers (3)
Clinical issues in transgender people (2)
Clinical issues in people who use drugs (4)
Cure interventions (5)
Nutrition (2)
Resistance to ART (19)
Impact of COVID-19 on HIV care (14)
Clinical manifestations and features of COVID-19 and HIV co-infection (6)
Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations (2)
HIV-exposed uninfected children (3)
TB/HIV co-infection in paediatric and adolescent populations (including treatment and prevention) (1)
Acute and early infection (1)
Track C
Epidemiology and prevention science
Natural history, morbidity patterns and survival (5)
Epidemiology of HIV in the general population (11)
Epidemiology of HIV in women (8)
Epidemiology of HIV in infants and children (4)
Epidemiology of HIV in adolescents (8)
Epidemiology of HIV in key populations (e.g., gay men and other men who have sex with men, sex workers, transgender people, people who inject rugs and prisoners and other incarcerated people)) (26)
Risk factors for acquisition, infectivity and transmission of HIV (8)
Epidemiology of AIDS events (e.g., AIDS-related opportunistic infections and cancers) (8)
Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) (26)
Epidemiology of non-AIDS non-communicable diseases (e.g., non-AIDS cancers, CVD) (10)
Describing the spread of HIV through molecular epidemiology (2)
Surveillance of HIV in key populations (17)
Determining the incidence of HIV (6)
Detecting and monitoring acute and recent HIV infections (9)
Measuring HIV through population-based surveys (including the undiagnosed fraction) (6)
Measuring the population impact of prevention and treatment interventions (2)
Measuring the population-level impact of policy-level HIV interventions (1)
Monitoring and evaluation of health systems along the HIV cascade (7)
Describing the spread of HIV through geographical information systems (2)
Advances in public health surveillance and new approaches (5)
Measuring and evaluating quality of service provision and health outcomes through public health surveillance (2)
Modelling the impact of prevention strategies on the HIV epidemic (10)
Modelling the role of syndemics on the HIV epidemic (1)
Modelling future healthcare needs (2)
Modelling the impact of service models on the HIV epidemic (6)
Reaching and recruiting key populations for HIV prevention services (online, offline, online-to-offline) (8)
Demonstration and pilot projects for prevention (including PrEP, PEP, male circumcision) (16)
Demand creation for PrEP use (10)
Scale up of PrEP (40)
Scale up of PEP (4)
Scale up of medical male circumcision (6)
Integrating STI, sexual and reproductive health and HBV and HCV services in HIV prevention programmes (12)
HIV prevention services for key populations (33)
Sexuality, gender and prevention technologies (including condoms, treatment as prevention, medical male circumcision, pre-exposure prophylaxis) (13)
Access to harm reduction interventions (11)
Optimizing vertical transmission prevention programmes (1)
Combination prevention strategies (5)
Prevention of vertical transmission (6)
Innovative behavioural prevention interventions (8)
Structural HIV prevention interventions (1)
Other new HIV prevention tools (11)
Measuring and enhancing retention and adherence in HIV prevention programmes (16)
Key population-led prevention programmes (from reach, recruit, test, treat, prevent and retain) (1)
Demand creation for HIV testing (1)
Facility-based HIV testing strategies (4)
Community-based HIV testing strategies (9)
Peer-led HIV testing strategies (6)
HIV testing with virtual and/or digital support (4)
HIV self-testing (36)
HIV testing algorithms (1)
HIV testing to support prevention (3)
HIV testing to support identification of new cases of people living with HIV (18)
Integration of HIV testing with other services (4)
Strategies to improve HIV linkage and ART initiation (11)
Strategies to improve early retention in care (first year on ART) (4)
Strategies to improve retention in care beyond the first year on ART (5)
Strategies to improve re-engagement (5)
Epidemiology of COVID-19 (5)
Epidemiology of COVID-19 among persons living with HIV and / or including tuberculosis (8)
Effects of the COVID-19 on HIV epidemiology and prevention (24)
COVID-19 testing (2)
COVID-19 prevention (18)
Track D
Social and behavioural science
Community engagement in research and research dissemination (10)
Knowledge translation and dissemination of research and programme outcomes (14)
Mixed methods, integrated approaches and synergies in HIV research and intervention (8)
Qualitative and ethnographic methods in HIV research (8)
Role of social and behavioural science in biomedical responses (3)
Social and behavioural concepts and theories (3)
Strengthening social and behavioural data collection and analysis (5)
Gay men other men who have sex with men (38)
Sex workers (29)
People who inject drugs (12)
Transgender people (16)
Prisoners and other incarcerated people (8)
Young key populations (50)
Other populations vulnerable in specific contexts (21)
Community mobilization and demand creation (15)
Community-based approaches (including empowerment, outreach and service delivery) (53)
Comprehensive sexuality education (6)
Couples- or family-centred approaches (7)
Harm reduction (11)
Intersectional identities and multiple vulnerabilities to HIV and co-infections (8)
Behavioural factors impacting acceptability and uptake of an HIV vaccine (6)
Interventions to reduce stigma and discrimination (22)
Other behavioural approaches (15)
Conceptualizing social and structural factors and their impacts (32)
Dynamics of social status and power: Sex, gender, age, race/ethnicity, sexual orientation and disability (12)
Economic transitions and social and cultural changes affecting HIV and the HIV response (3)
Humanitarian crises and HIV (5)
Intergenerational and/or transactional sex (1)
Media, cultural and religious representations of HIV and of key populations (3)
Migration and HIV (10)
Political and structural factors (1)
Sexual- and/or gender-based violence and exploitation (including in conflict settings) (11)
Societal stigma towards people living with HIV and key populations (35)
Socioeconomic differences: Poverty, wealth and income inequalities (5)
Violence and conflict: Political, social, structural, interpersonal and family-based (4)
Risk compensation: Conceptualization, assessment and mitigation (2)
Adolescents, sexuality and relationships (9)
Gender issues and gendered relationships (8)
Gender-transformative approaches (3)
Sexual concurrency and sexual networks (1)
Sexualities and sexual cultures: Meanings, identities, norms and communities (2)
Adaptation to living with HIV for individuals, families and communities (5)
Ageing with HIV (5)
Confronting stigma: Lessons learned (8)
Experiences and impacts of antiretroviral therapy (5)
Growing up with HIV: Specific needs and interventions for children and adolescents (9)
HIV and the workplace: Policies, responding to stigma and/or discrimination, unemployment, return to work and rehabilitation (3)
Living with HIV and co-infections and/or co-morbidities (9)
Peer support: Lessons learned, access to services and health outcomes (5)
Positive health, dignity, psychological well-being and mental health (11)
Prevention interventions and their effects on the lives and relationships of people living with HIV (5)
Sexual and reproductive health, fertility, family planning, pregnancy and abortion (12)
COVID-19 social distancing and curfews: Implications for access to HIV care (18)
Social and behavioural aspects and approaches to COVID-19 (36)
COVID-19: Associated mental health challenges for people living with HIV (5)
Effects of the COVID-19 on key populations (31)
Track E
Implementation science, economics, systems and synergies with other health and development sectors
Implementation science of scaling up prevention (including PrEP) (37)
Implementation science of scaling up HIV testing (20)
Implementation science of scaling up HIV treatment (29)
Scaling up access to models of integrated services (HIV, hepatitis, STI and other services, such as harm reduction, SRHR, gender affirming care, TB, NCDs and mental health) (41)
Strategies to enhance U=U communication and implementation (11)
Implementation of HIV status-neutral approach to enhance HIV testing, HIV prevention and HIV treatment services (3)
Approaches to viral load monitoring at scale (6)
Innovations and lessons for supporting HIV prevention effective use and treatment adherence (28)
Scaling up services for adolescents and youth (5)
Differentiated service delivery for HIV testing, prevention and treatment (33)
Strategies to increase retention and re-engagement in HIV services (23)
National financing analyses and financing mechanisms for HIV, hepatitis and STI programmes and services (6)
Transitional financing (3)
International assistance, frameworks and funding mechanisms for HIV, hepatitis and STI programmes and services (2)
Financing HIV within UHC frameworks (4)
Approaches to achieving sustainability, including sustainable financing for civil society (17)
Approaches and evidence from cross-sectoral programming and financing (5)
Costing of HIV, hepatitis and STI services (12)
Assessments of cost effectiveness: Provider and community perspectives (4)
Economic evaluation and affordability assessments (8)
Supporting effective linkages between maternal child health and HIV services (1)
Approaches to supporting resilient health systems (17)
Making health systems work for adolescents (2)
Community participation in systems for health, including community-led and key population-led health systems (14)
Approaches to effective paediatric HIV services (4)
Getting policies into practice (9)
Systems serving underserved populations (14)
Evidence on task sharing (1)
Systems to deliver effective, long-term chronic care (6)
Public-private partnerships (3)
Combination programming on social drivers of HIV (including education, violence and workplaces) (4)
Delivering gender-transformative programmes and tackling violence against women and girls: Programmatic lessons (2)
Social protection: New evidence and programmatic lessons (6)
Innovations in behavioural data collection and use (2)
Innovative approaches to track individuals (3)
Innovative uses of data to strengthen systems and programmes (21)
Approaches to using data to improve programming (19)
Evaluating large-scale programmes: Approaches to rigorous evaluation (4)
Effective approaches to linking population and programme data to inform HIV programming (3)
Data and accountability and transparency (6)
Monitoring and reporting in the SDG era (3)
Using big data in the HIV response (1)
Impact of COVID-19 on HIV prevention services (12)
Impact of COVID-19 on HIV testing services (9)
Impact of COVID-19 on HIV treatment services (18)
Impact of COVID-19 on financing for the HIV response (3)
Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era (30)
Financing HIV, hepatitis and STI testing and drug access: The economics of generics and differential pricing structures (2)
Track F
Political science, laws, ethics, policies and human rights
Laws and policies on reproduction (including coerced sterilization and abortion) (1)
Laws and policies on HIV transmission, exposure, and non-disclosure (11)
Laws, policies and practices impacting access to HIV testing, prevention, treatment, care and support (17)
Laws and policies regulating access to drugs and medical devices (including intellectual property and trade regimes, competition law and price regulation) (12)
Challenging criminalization/penal provisions relating to gender and sexual diversity as an impediment to the global HIV response (6)
Conceptualizing political drivers and their impacts (3)
Antiretroviral procurement and supply chain management (1)
Humanitarian crises (2)
Sexual- and/or gender-based inequalities, inequities and violence (10)
Access to education (3)
Criminalization, incarceration and living in closed settings (2)
Availability and access to harm reduction (including OST and NSP) (3)
Financial incentives, micro-finance and other economic approaches (1)
Safe housing, social protection and other care and support for people affected by HIV (1)
Access to appropriate healthcare services (including for co-infections and co-morbidities) (4)
Effective models of NGO structure, funding, partnership, strategy and community participation (7)
Human rights of people living with HIV and key populations (26)
Gender equity and diversity (5)
Sexual and reproductive health and rights (4)
Children’s rights and HIV (4)
Representations of stigma: Social attitudes, media and public debate (4)
Racism and other forms of ethnicity-based social exclusion (1)
Experiences and impacts of homophobia and transphobia (1)
Human rights programmes (6)
Legal advocacy tools and strategies  (10)
Stigma and key populations (13)
Discrimination and key populations (8)
Punitive laws and enforcement practices directed at or impacting on key populations) (5)
Investing in regional HIV programmes and regional key population movements (5)
Ethical aspects and standards in research (including clinical trials) (8)
Ethical aspects and standards in prevention programmes (1)
Ethical aspects of public health policy and programmes (including allocation of resources) (1)
Inclusion considerations for research and development and other trials (2)
Policies regarding HIV services and programmes (4)
Policies addressing social and economic determinants of vulnerability (1)
Policies addressing HIV in the workplace and/or educational institutions (1)
Policies related to treatment access (including intellectual property policy) (1)
Monitoring and evaluation of policies and their impact on people living with HIV and key populations (2)
Policies supporting increased demand, uptake and retention of key populations for HIV services and programmes (4)
COVID-19 and politics, human rights, ethics or policy (9)
Impact of COVID-19 on HIV risk and HIV care among refugees, migrants, asylum seekers and internally displaced persons (8)
Political violence and armed conflict (2)
Migration (2)
Integration of HIV with other health services (including co-infections and NCDs) (2)
Accountability on the HIV response (2)
Foregrounding accountability within the HIV response (1)
Challenging criminalization of sexuality, gender identity and bodily autonomy as a driver of HIV programme exclusion (1)
Law enforcement and public health (1)
Filter
Abstract Type
Filter
Tracks